Showing results (1691-1700 of 2,162) with videos related to

Sort By:
Pageof 217
Drug and Alcohol Review|June 9, 2021
Estimating population-level of alcohol, tobacco and morphine use in a small Russian region using wastewater-based epidemiologyVladimir V Rozhanets, Phong K Thai, Artemy S Silantyev, et al.
Environment International|December 2, 2017
Urinary metabolites of organophosphate esters: Concentrations and age trends in Australian childrenChang He, Leisa-Maree L Toms, Phong Thai, et al.
Plos One|April 26, 2018
Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 inductionJohn D Belcher, Chunsheng Chen, Julia Nguyen, et al.
The Science of the Total Environment|November 4, 2023
Biomining for sustainable recovery of rare earth elements from mining waste: A comprehensive reviewPhong H N Vo, Soroosh Danaee, Ho Truong Nam Hai, et al.
The Application of Clinical Genetics|May 5, 2026
Clinical Feasibility of Early First-Trimester Non-Invasive Prenatal Testing: Associations Between Gestational Age, Fetal Fraction, and No-Call RatesTrinh The Son, Sang Trieu Tien, Tran Van Khoa, et al.
Global Health, Science and Practice|November 4, 2022
Establishing a Standardized Surveillance System for Health Care-Associated Infections in VietnamDaniella Coker, Ha Thi Kim Phuong, Lan Thi Phong Nguyen, et al.
Journal of Leukocyte Biology|November 10, 2023
NKG2D receptor signaling shapes T cell thymic educationCynthia Perez, Lourdes Plaza-Rojas, Justin C Boucher, et al.
Journal of Clinical Microbiology|December 21, 2018
Impact of External Quality Assurance on the Quality of Xpert MTB/RIF Testing in Viet NamVidyanidhi Gumma, Kyle DeGruy, Davara Bennett, et al.
Journal of Medicinal Chemistry|August 27, 2021
Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 (S)-5-(1-((1-Acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one, by Fragment-Based Drug DesignMark Sabat, Douglas R Dougan, Beverly Knight, et al.
American Heart Journal|October 2, 2004
N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-upSteven E S Miner, Vladimir Dzavik, Phong Nguyen-Ho, et al.
Pageof 217